Health Subcommittee to Hear from FDA, Stakeholders at Hearing TOMORROW
Reports Raise Questions Over Who Was Involved in Drafting FDA’s Proposed Change to Generic Drug LabelingMarch 31, 2014 | ICYMI
The Energy and Commerce Committee’s bipartisan investigation into the General Motors recall will continue next week with an Oversight and Investigations Subcommittee hearing on Tuesday, April 1, featuring testimony from GM CEO Mary Barra and National Highway Traffic Safety Administration Acting Administrator David Friedman.
In the wake of Russia’s aggressive actions toward Ukraine, calls for action on LNG exports continue to grow louder.
The Price of Incompetence: Obamacare’s Many Changes, Delays Expected to Enflame #RateShock
LA Times Shares Committee’s Concerns About FDA’s Proposed Changes to Generic Drug Labels Health Subcommittee Hearing to Review Proposed Changes Rescheduled for April 1
OPINION: Rep. Marsha Blackburn in The Daily Caller: After 2,000 days in limbo, will Obama finally approve the Keystone pipeline?March 12, 2014 | ICYMI
March 12, 2014